Anticoagulation for Stroke Prevention of Concomitant Atrial Fibrillation and End-Stage Renal Disease: Insights of Cardiologists and Nephrologists From India

Introduction Patients with concomitant atrial fibrillation (AF) and end-stage renal disease (ESRD) are at increased risk of thrombosis and bleeding. Diligent anticoagulant therapy that prevents major bleeding is essential for stroke prevention. There is a dearth of evidence and guidance on anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: ES, Swetha, Taur, Santosh, Kulkarni, Namrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857051/
https://www.ncbi.nlm.nih.gov/pubmed/36694536
http://dx.doi.org/10.7759/cureus.32788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857051/
https://www.ncbi.nlm.nih.gov/pubmed/36694536
http://dx.doi.org/10.7759/cureus.32788

Ejemplares similares